Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	163.54	23.36	14.47	14.22	32.94	12.6
Short-Term Investments	61.98	74.36	37.75	37.93	12.09	82.44
Cash & Short-Term Investments	225.52	97.72	52.23	52.15	45.02	95.03
Cash Growth	83.78%	87.11%	0.15%	15.82%	-52.62%	-26.48%
Accounts Receivable	-	-	-	-	3	-
Other Receivables	1.63	1.65	2.44	0.19	-	-
Receivables	1.63	1.65	2.44	0.19	3	-
Prepaid Expenses	2.09	1.14	0.73	0.42	2.38	2.71
Restricted Cash	0.34	0.34	0.34	0.34	5.89	-
Total Current Assets	232.26	100.85	55.74	53.1	56.29	97.74
Property, Plant & Equipment	13.63	7.98	7.99	11.07	21.74	18.35
Goodwill	-	-	-	-	-	32.47
Other Intangible Assets	-	-	-	-	1.38	1.5
Other Long-Term Assets	0.34	0.1	0.28	0.04	0.17	1.14
Total Assets	246.23	108.93	64	64.21	79.59	151.2
Accounts Payable	7.34	3.44	1.86	1.81	4.33	4.7
Accrued Expenses	5.5	6.33	5.99	3.99	5.59	3.41
Current Portion of Long-Term Debt	5.56	5.93	-	-	-	0.33
Current Portion of Leases	0.54	0.82	1	1.77	1.82	1.71
Current Unearned Revenue	-	-	-	-	-	0.3
Other Current Liabilities	0.08	0.06	4.58	0.2	4.9	31.52
Total Current Liabilities	34.52	16.59	13.42	7.78	16.62	41.96
Long-Term Debt	14.01	13.04	-	-	-	1.43
Long-Term Leases	3.98	3.26	4.4	5.85	7.56	5.26
Other Long-Term Liabilities	30.16	32.01	31.35	23.82	13.04	-
Total Liabilities	82.66	64.9	49.18	37.45	37.22	48.65
Common Stock	0.51	0.46	0.27	0.18	1.47	0.96
Additional Paid-In Capital	879.56	856.82	764.15	722.05	696.56	672.3
Retained Earnings	-716.45	-813.26	-749.52	-695.34	-655.64	-570.7
Comprehensive Income & Other	-0.05	0.01	-0.07	-0.13	-0.03	-0.01
Shareholders' Equity	163.58	44.03	14.83	26.76	42.37	102.55
Total Liabilities & Equity	246.23	108.93	64	64.21	79.59	151.2
Total Debt	24.08	23.05	5.4	7.63	9.38	8.73
Net Cash (Debt)	201.44	74.67	46.83	44.52	35.65	86.3
Net Cash Growth	102.37%	59.47%	5.17%	24.90%	-58.70%	-28.86%
Net Cash Per Share	3.55	1.82	2.19	5.66	9.05	23.28
Filing Date Shares Outstanding	51.28	48.53	27.36	17.71	5.9	3.95
Total Common Shares Outstanding	51.25	45.64	26.52	17.72	5.89	3.85
Working Capital	197.75	84.27	42.32	45.32	39.67	55.78
Book Value Per Share	3.19	0.96	0.56	1.51	7.20	26.67
Tangible Book Value	163.58	44.03	14.83	26.76	40.98	68.59
Tangible Book Value Per Share	3.19	0.96	0.56	1.51	6.96	17.84
Machinery	11.83	9.98	7.92	9.02	10.98	9.98
Construction In Progress	4.8	0.62	-	-	3.22	0.07
Leasehold Improvements	8.91	8.81	8.6	8.61	8.6	8.6

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q